Case Studies > Global Pharmaceutical Company Fills its Detection and Remediation Gaps

Global Pharmaceutical Company Fills its Detection and Remediation Gaps

Customer Company Size

Large Corporate

Region

Asia
Europe

Country

United States

Product

Cybereason Platform
Cybereason Incident and Response Console

Tech Stack

Endpoint Detection and Response
Next-Generation Antivirus
Active Monitoring Services

Implementation Scale

Enterprise-wide Deployment

Impact Metrics

Productivity Improvements
Cost Savings
Customer Satisfaction

Technology Category

Cybersecurity & Privacy - Endpoint Security
Cybersecurity & Privacy - Malware Protection
Cybersecurity & Privacy - Intrusion Detection

Applicable Industries

Pharmaceuticals

Applicable Functions

Business Operation

Use Cases

Intrusion Detection Systems
Remote Asset Management

Services

Cybersecurity Services
System Integration

About The Customer

The customer is one of the world's largest pharmaceutical companies, with annual revenue in the billions of dollars. As a global leader in the pharmaceutical industry, the company is responsible for protecting an intellectual property portfolio worth billions. This requires robust security measures to safeguard sensitive data and maintain business continuity. The company operates on a large scale, with approximately 100,000 employees and a vast network of endpoints that need to be secured against cyber threats. Given the complexity and scale of its operations, the company requires advanced security solutions to protect its assets and ensure the safety of its operations.

The Challenge

The company faced significant challenges in detecting and responding to advanced security threats. Despite having top-tier antivirus software and a well-maintained SIEM configuration, malware continued to infiltrate their systems. The security team struggled to identify the source of these threats and assess their severity and impact. This lack of visibility forced the company to take an extreme approach to remediation, re-imaging any machine detected as infected. This process was costly and disruptive, affecting business continuity and worker productivity. The company needed a solution that could provide continuous endpoint visibility and context around detected incidents to enable a smarter, scalable remediation strategy.

The Solution

The company deployed the Cybereason platform on 4,000 endpoints in one of its business units. Cybereason provided immediate detection of signature-based threats that the existing antivirus software failed to catch. The platform automated the task of updating the malware signature database, ensuring it always contained the latest known threats. Cybereason also provided detailed attack context, enabling the security team to understand the full scope of an attack, including which machines were infected, how adversaries infiltrated the company, and the extent of the damage. This information empowered junior analysts to shut down threats effectively. The platform's Incident and Response Console allowed analysts to remotely view and take action across the company's IT environment, reducing the need for re-imaging infected machines.

Operational Impact

The deployment of Cybereason led to a significant reduction in the need for computer re-imaging, freeing up IT resources and improving business continuity.
The security team gained a comprehensive understanding of attacks, allowing for more effective threat remediation and reducing the impact on business operations.
Employees were able to maintain productivity as they no longer had to surrender their computers for re-imaging, enhancing overall business efficiency.

Quantitative Benefit